Latest Covid Study Pause Puts Stock Rallies at Risk for Other Vaccine Makers
South Africa in the news: Latest Covid Study Pause Puts Stock Rallies at Risk for Other Vaccine Makers: Study and trial pauses can be a standard operating procedure in drug development, yet it could put the triple- and quadruple-digit rallies for some biotechs at risk.With more than 40 trials testing Co …: “South Africa” – …
